Business
Approval to commence dosing 3rd cohort of ISLA-101 SAD study
Approval to commence dosing 3rd cohort of ISLA-101 SAD study
About this update from Island Pharmaceuticals Ltd
[{"type":"text","content":"Island Pharmaceuticals Ltd has released a press release. View Attachment","length":257,"tagName":"div"}]